Nazwa produktu: |
11β,17β-dihydroksy-17-metyloandrost-4-en-3-on |
Synonimy |
Testosteron, 11beta-hydroksy-17-metylo-; 17-alfa-metylo-11-beta,17-dihydroksy-4-androsten-3-on; 17alfa-metylo-11beta,17-dihydroksy-4-androsten-3-on; 4-08-00-02056 (Odniesienie do podręcznika Beilstein); Androst-4-en-3-on, 11beta,17beta-dihydroksy-17-metylo-;BA 51-08943; BRN 3214017; NSC 11677; NSC 3359; U 5437; U-5437; 11beta,17beta-dihydroksy-17-metyloandrost-4-en-3-on; Androst-4-en-3-on, 11,17-dihydroksy-17-metylo-, (11beta,17beta)-(9CI); Androst-4-en-3-on, 11-beta,17-beta-dihydroksy-17-metylo-; Androst-4-en-3-on, 11,17-dihydroksy-17-metylo-, (11-beta,17-beta)-; (11beta,17beta)-11,17-dihydroksy-17-metyloandrost-4-en-3-on |
Angielska nazwa |
11β,17β-dihydroxy-17-methylandrost-4-en-3-one;Testosterone, 11beta-hydroxy-17-methyl-; 17-alpha-Methyl-11-beta,17-dihydroxy-4-androsten-3-one; 17alpha-Methyl-11beta,17-dihydroxy-4-androsten-3-one; 4-08-00-02056 (Beilstein Handbook Reference); Androst-4-en-3-one, 11beta,17beta-dihydroxy-17-methyl-; BA 51-08943; BRN 3214017; NSC 11677; NSC 3359; U 5437; U-5437; 11beta,17beta-Dihydroxy-17-methylandrost-4-en-3-one; Androst-4-en-3-one, 11,17-dihydroxy-17-methyl-, (11beta,17beta)- (9CI); Androst-4-en-3-one, 11-beta,17-beta-dihydroxy-17-methyl-; Androst-4-ene-3-one, 11,17-dihydroxy-17-methyl-, (11-beta,17-beta)-; (11beta,17beta)-11,17-dihydroxy-17-methylandrost-4-en-3-one |
MF |
C20H30O3 |
Masie cząsteczkowej |
318.4504 |
InChI |
InChI=1/C20H30O3/c1-18-8-6-13(21)10-12(18)4-5-14-15-7-9-20(3,23)19(15,2)11-16(22)17(14)18/h10,14-17,22-23H,4-9,11H2,1-3H3/t14-,15-,16-,17+,18-,19-,20-/m0/s1 |
Nr CAS |
1043-10-3 |
EINECS |
213-871-9 |
Struktury molekularnej |
|
Gęstość |
1.17g/cm3 |
Temperatura wrzenia |
475.5°C at 760 mmHg |
Współczynnik załamania |
1.573 |
Temperatura zapłonu |
255.5°C |
Ciśnienie pary |
4.87E-11mmHg at 25°C |
Symbole zagrożenia |
|
Kody ryzyka |
|
Bezpieczeństwo opis |
|
|